Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Van Puyenbroeck

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Life Sciences : CMLS|January 7, 2018
Inhibitors of protein translocation across membranes of the secretory pathway: novel antimicrobial and anticancer agentsVictor Van Puyenbroeck, Kurt Vermeire
Molecular & Cellular Proteomics : MCP|December 22, 2016
A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA)Victor Van Puyenbroeck, Elisa Claeys, Dominique Schols, et al.
Journal of Medicinal Chemistry|March 15, 2016
Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating PotenciesReena Chawla, Victor Van Puyenbroeck, Nicholas C Pflug, et al.
Traffic (Copenhagen, Denmark)|November 2, 2019
Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamideVictor Van Puyenbroeck, Eva Pauwels, Becky Provinciael, et al.
Plos Biology|December 3, 2014
Signal peptide-binding drug as a selective inhibitor of co-translational protein translocationKurt Vermeire, Thomas W Bell, Victor Van Puyenbroeck, et al.
Mbio|July 3, 2014
Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogensYves Briers, Maarten Walmagh, Victor Van Puyenbroeck, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Life Sciences : CMLS|January 7, 2018
Inhibitors of protein translocation across membranes of the secretory pathway: novel antimicrobial and anticancer agentsVictor Van Puyenbroeck, Kurt Vermeire
Molecular & Cellular Proteomics : MCP|December 22, 2016
A Proteomic Survey Indicates Sortilin as a Secondary Substrate of the ER Translocation Inhibitor Cyclotriazadisulfonamide (CADA)Victor Van Puyenbroeck, Elisa Claeys, Dominique Schols, et al.
Journal of Medicinal Chemistry|March 15, 2016
Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating PotenciesReena Chawla, Victor Van Puyenbroeck, Nicholas C Pflug, et al.
Traffic (Copenhagen, Denmark)|November 2, 2019
Preprotein signature for full susceptibility to the co-translational translocation inhibitor cyclotriazadisulfonamideVictor Van Puyenbroeck, Eva Pauwels, Becky Provinciael, et al.
Plos Biology|December 3, 2014
Signal peptide-binding drug as a selective inhibitor of co-translational protein translocationKurt Vermeire, Thomas W Bell, Victor Van Puyenbroeck, et al.
Mbio|July 3, 2014
Engineered endolysin-based "Artilysins" to combat multidrug-resistant gram-negative pathogensYves Briers, Maarten Walmagh, Victor Van Puyenbroeck, et al.
Pageof 1